Mar 17 |
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
|
Mar 16 |
NASH drug market expected to surpass $48B by 2035
|
Mar 15 |
Wegovy and Zepbound Cast Shadow Over Madrigal’s Liver Drug
|
Mar 15 |
Geron, Madrigal Pharmaceuticals jump on good news from FDA
|
Mar 15 |
Madrigal Pharmaceuticals Stock Surges After FDA Approves Liver Disease Treatment
|
Mar 15 |
Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge
|
Mar 15 |
US STOCKS-Wall St slides as inflation woes dampen rate-cut bets
|
Mar 15 |
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
|
Mar 15 |
Biggest stock movers today: RIVN, ADBE, GERN, and more
|
Mar 15 |
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
|